Medical intermediate turnover tank

Abstract

The utility model relates to the technical field of turnover tanks, in particular to a medical intermediate turnover tank which is characterized in that in the use process, when medical intermediates are transferred and stored in a tank body, an anti-precipitation component is started, so that the medical intermediates are prevented from precipitating in the tank body, the medical intermediates can be quickly put into use, and the convenience is improved; comprising a supporting plate, a tank body, a cover plate, bottom plates and a supporting rod, the bottom plates are arranged at the top end of the supporting rod, the top ends of the bottom plates are connected with the bottom end of the supporting plate, the tank body is arranged at the top end of the supporting plate, the cover plate is arranged at the top end of the tank body, and the anti-precipitation assembly is arranged on the supporting plate.

Description

TECHNICAL FIELD

[0001] The utility model relates to the technical field of turnover tank, in particular to a kind of medical intermediates turnover tank. BACKGROUND

[0002] Medical intermediates, in fact, are some chemical raw materials or chemical products used in the process of drug synthesis, which can be produced in ordinary chemical plants without drug production license; after processing, medical intermediates need to be stored in turnover barrels.

[0003] In the prior art, the patent document with the publication number CN210012089U discloses a medical intermediate turnover barrel, which includes a cylinder, an outer cover is slidably connected to the outer surface of the upper end of the cylinder, an inner cover plate is fixedly connected to the inner surface of the outer cover through a first spring, the outer surface of the inner cover plate is slidably connected to the inner surface of the upper end of the cylinder through a circular groove, a clamping block and a second spring are slidably connected to the inner surface of the protrusions at the front and rear ends of the outer cover through a sliding groove, the inner end surface of the clamping block is slidably connected to the inner surface of the upper end of the cylinder through a clamping groove, a pull pin is fixedly connected to the outer end surface of the clamping block, a pull ring is fixedly connected to the outer surface of the pull pin, and a circular recess is provided on the outer end surface of the protrusions at the front and rear ends of the outer cover.

[0004] During use, it was found that the above-mentioned device does not have a sedimentation prevention function. When in use, the medical intermediates need to be stirred, which requires the use of a professional stirring device for stirring, and it takes a long time to mix the medical intermediates uniformly so that they do not settle, and then they can be used. However, if the medical intermediates are urgently needed, there is no way to quickly process and put them into use. UTILITY MODEL CONTENTS

[0005] To solve the above technical problems, the utility model provides a medical intermediate turnover tank with a sedimentation prevention function.

[0006] The medical intermediate turnover tank of the utility model includes a supporting plate, a tank body, a cover plate, a bottom plate and a supporting rod, the top end of the supporting rod is provided with a plurality of bottom plates, the top end of each of the plurality of bottom plates is connected to the bottom end of the supporting plate, the top end of the supporting plate is provided with the tank body, and the top end of the tank body is provided with the cover plate. The utility model also includes a sedimentation prevention assembly, which is arranged on the supporting plate. During use, when the medical intermediates are transferred and stored in the tank body, the sedimentation prevention assembly is started to prevent the medical intermediates from settling in the tank body, ensuring quick use and improving convenience.

[0007] Preferably, the anti-settling assembly comprises a pump body, a first infusion tube, a tee joint, an external discharge pipe, an external discharge valve and a stirring assembly, the pump body is arranged at the top end of the bottom plate, the input end of the pump body is provided with the first infusion tube, the input end of the first infusion tube extends into the tank body, the output end of the pump body is provided with the tee joint, the first group of output ends of the tee joint are provided with the external discharge pipe, the external discharge valve is arranged on the external discharge pipe, the second group of output ends of the tee joint are in communication with the input end of the stirring assembly, and the stirring assembly is arranged in the tank body; the external discharge valve is closed, and the pump body is started, so that the pharmaceutical intermediates in the tank body are returned to the tank body through the stirring assembly while the stirring assembly stirs the pharmaceutical intermediates in the tank body, the settling of the pharmaceutical intermediates is prevented, and the pharmaceutical intermediates can be discharged through the external discharge pipe when the pharmaceutical intermediates need to be discharged, thereby improving convenience.

[0008] Preferably, the stirring assembly comprises a reflux pipe, a rotary joint, a shell, L-shaped nozzles, stirring blades, a reflux valve and a second infusion tube, the second group of output ends of the tee joint are provided with the reflux pipe, the top end of the reflux pipe extends into the tank body and is in rotary communication with the bottom end of the second infusion tube through the rotary joint, the top end of the second infusion tube is in communication with the bottom end of the shell, a plurality of groups of L-shaped nozzles are arranged on the outer side wall of the shell in a circumferential direction, a plurality of groups of stirring blades are arranged on the outer side wall of the second infusion tube, and the reflux valve is arranged on the reflux pipe; the external discharge valve is closed and the reflux valve is opened, so that the pharmaceutical intermediate solution enters the shell through the reflux pipe, the rotary joint and the second infusion tube, and when the pharmaceutical intermediate solution is sprayed out of the shell through the plurality of groups of L-shaped nozzles, the shell drives the second infusion tube to rotate, and the plurality of groups of stirring blades further mix and stir the pharmaceutical intermediates in the tank body, thereby preventing the settling of the pharmaceutical intermediates.

[0009] Preferably, the handle is arranged at the top end of the cover plate; and the cover plate is opened or closed by the pump body, thereby improving convenience.

[0010] Preferably, the adjustable feet are arranged at the bottom end of the bottom plate; and the four groups of adjustable feet stably support the device, thereby improving stability.

[0011] Preferably, the observation window is arranged on the tank body; and the liquid level of the pharmaceutical intermediates in the tank body is observed through the observation window, thereby improving convenience.

[0012] Compared with the prior art, the anti-settling assembly is started when the pharmaceutical intermediates are transferred and stored in the tank body during use, so that the settling of the pharmaceutical intermediates in the tank body is avoided, rapid use is ensured, and convenience is improved. BRIEF DESCRIPTION OF DRAWINGS

[0013] Figure 1 is a perspective view of the utility model;

[0014] Figure 2 is an explosion structure schematic diagram of the utility model;

[0015] Figure 3 is an enlarged structure schematic diagram of the support rod and the adjustable foot and the like structure;

[0016] Figure 4 is an enlarged structure schematic diagram of the observation window and the handle and the like structure;

[0017] Figure 5 is an enlarged structure schematic diagram of the shell and the pump body and the like structure.

[0018] Markings in the drawing: 1, supporting plate; 2, tank body; 3, cover plate; 4, bottom plate; 5, support rod; 6, pump body; 7, No. 1 infusion tube; 8, three-way pipe; 9, external discharge pipe; 10, external discharge valve; 11, return pipe; 12, rotary joint; 13, shell; 14, L-shaped spray head; 15, stirring piece; 16, handle; 17, adjustable foot; 18, observation window; 19, return valve; 20, No. 2 infusion tube. DETAILED DESCRIPTION

[0019] In order to facilitate understanding of the utility model, the utility model will be described more fully below with reference to the relevant drawings. The utility model can be realized in many different forms and is not limited to the embodiments described herein. On the contrary, the purpose of providing these embodiments is to make the disclosure of the utility model more thorough and comprehensive.

[0020] Embodiment 1

[0021] As shown in Figure 1 , Figure 2 , Figure 3 and Figure 4 , the utility model discloses a medical intermediate turnover tank, including supporting plate 1, tank body 2, cover plate 3, bottom plate 4 and support rod 5, the support rod 5 top end is provided with multiple sets of bottom plate 4, and the multiple sets of bottom plate 4 top end are all connected with supporting plate 1 bottom end, and the supporting plate 1 top end is provided with tank body 2, and the tank body 2 top end is provided with cover plate 3, further including anti-settling subassembly, and the supporting plate 1 is provided with anti-settling subassembly;

[0022] As shown in Figure 5 , the anti-settling subassembly includes pump body 6, No. 1 infusion tube 7, three-way pipe 8, external discharge pipe 9, external discharge valve 10 and stirring assembly, the bottom plate 4 top end is installed with pump body 6, and the pump body 6 input end is provided with No. 1 infusion tube 7, and the No. 1 infusion tube 7 input end extends to the inside of tank body 2, the pump body 6 output end is provided with three-way pipe 8, the first set of output end of three-way pipe 8 is provided with external discharge pipe 9, and the external discharge pipe 9 is installed with external discharge valve 10, and the second set of output end of three-way pipe 8 is communicated with the input end of stirring assembly, and the stirring assembly is arranged in the inside of tank body 2.

[0023] In this embodiment, during use, when the pharmaceutical intermediates are temporarily stored inside the tank 2, the discharge valve 10 is closed, and the pump body 6 is started, so that the pharmaceutical intermediates inside the tank 2 are stirred by the stirring assembly and returned to the tank 2, preventing precipitation. When it is necessary to discharge the pharmaceutical intermediates, the discharge valve 10 is opened, so that the pharmaceutical intermediates can be discharged through the discharge pipe 9.

[0024] Embodiment 2

[0025] As shown in Figure 1 , Figure 2 , Figure 3 and Figure 4 , the utility model discloses a pharmaceutical intermediate turnover tank, including the supporting plate 1, the tank 2, the cover plate 3, the bottom plate 4 and the support rod 5, the support rod 5 top is provided with a plurality of bottom plate 4, and a plurality of bottom plate 4 top all are connected with the supporting plate 1 bottom end, and the supporting plate 1 top is provided with the tank 2, and the tank 2 top is provided with the cover plate 3, still including anti-settling assembly, be provided with anti-settling assembly on the supporting plate 1;

[0026] As shown in Figure 5 , the anti-settling assembly includes a pump body 6, a first infusion tube 7, a tee pipe 8, a discharge pipe 9, a discharge valve 10 and a stirring assembly, the bottom plate 4 top is installed with the pump body 6, and the pump body 6 input is provided with the first infusion tube 7, and the first infusion tube 7 input extends to the tank 2 inside, the pump body 6 output is provided with the tee pipe 8, and the tee pipe 8 first group output is provided with the discharge pipe 9, and the discharge pipe 9 is installed with the discharge valve 10, and the tee pipe 8 second group output is communicated with the stirring assembly input, and the stirring assembly is set in the tank 2 inside;

[0027] As shown in Figure 2 and Figure 5 , the stirring assembly includes a return pipe 11, a rotary joint 12, a shell 13, an L-shaped nozzle 14, a stirring blade 15, a return valve 19 and a second infusion tube 20, the tee pipe 8 second group output is provided with the return pipe 11, and the return pipe 11 top extends to the tank 2 inside and is communicated with the second infusion tube 20 bottom end rotation through the rotary joint 12, and the second infusion tube 20 top is communicated with the shell 13 bottom end, and the shell 13 outside wall is provided with a plurality of L-shaped nozzles 14, and the second infusion tube 20 outside wall is provided with a plurality of stirring blades 15, and the return pipe 11 is provided with the return valve 19;

[0028] Still including handle 16, adjustable foot 17 and observation window 18, the cover plate 3 top is provided with handle 16, and the bottom plate 4 bottom end four corners are provided with a group of adjustable feet 17 respectively, and the tank 2 is provided with observation window 18.

[0029] In the use process of the embodiment, when the pharmaceutical intermediates are temporarily stored in the tank body 2, the exhaust valve 10 is closed and the reflux valve 19 is opened, so that the pharmaceutical intermediate solution enters the inside of the shell 13 through the reflux pipe 11, the rotary joint 12 and the second infusion pipe 20, and when the pharmaceutical intermediate solution is sprayed outside through the multiple groups of L-shaped nozzles 14, the shell 13 drives the second infusion pipe 20 to rotate, and further makes the multiple groups of stirring blades 15 mix and stir the pharmaceutical intermediates in the tank body 2, so as to prevent the generation of precipitates, and when it is necessary to exhaust the pharmaceutical intermediates, the exhaust valve 10 is opened, so that the pharmaceutical intermediates can be exhausted through the exhaust pipe 9.

[0030] The pump body 6 of the pharmaceutical intermediate turnover tank of the utility model is purchased on the market, and the technical personnel in the industry only needs to install and operate according to the use instruction book attached, without the creative labor of the technical personnel in the field.

[0031] The above is only the preferred embodiment of the utility model, and it should be pointed out that for ordinary technical personnel in the technical field, without departing from the technical principle of the utility model, a number of improvements and modifications can be made, and these improvements and modifications should also be regarded as the protection range of the utility model.

Claims

1. A medical intermediate product turnover tank, comprising a supporting plate (1), a tank body (2), a cover plate (3), a bottom plate (4) and a supporting rod (5), the top end of the supporting rod (5) is provided with a plurality of groups of bottom plates (4), the top end of each group of bottom plates (4) is connected with the bottom end of the supporting plate (1), the top end of the supporting plate (1) is provided with the tank body (2), and the top end of the tank body (2) is provided with the cover plate (3), characterized in that, Also include anti-settling components, the tray (1) is provided with anti-settling components.

2. A medical intermediate bulk container as defined in claim 1, wherein, Anti-settling components include pump body (6), No. 1 infusion tube (7), three-way pipe (8), discharge pipe (9), discharge valve (10) and stirring assembly, the bottom plate (4) top end is installed with pump body (6), the input end of pump body (6) is provided with No. 1 infusion tube (7), No. 1 infusion tube (7) input end extends to the inside of the jar (2), the output end of pump body (6) is provided with three-way pipe (8), the first group output end of three-way pipe (8) is provided with discharge pipe (9), discharge pipe (9) is installed with discharge valve (10), the second group output end of three-way pipe (8) and stirring assembly input end are communicated, and stirring assembly is arranged in the jar (2) inside.

3. A medical intermediate bulk container as defined in claim 2, wherein, Stirring assembly includes return pipe (11), rotary joint (12), shell (13), L-shaped nozzle (14), stirring blade (15), return valve (19) and No. 2 infusion tube (20), the second group output end of three-way pipe (8) is provided with return pipe (11), return pipe (11) top end extends to the inside of the jar (2) and is communicated with No. 2 infusion tube (20) bottom end rotationally through rotary joint (12), No. 2 infusion tube (20) top end and shell (13) bottom end are communicated, and the outer side wall of shell (13) is provided with multiple L-shaped nozzles (14), the outer side wall of No. 2 infusion tube (20) is provided with multiple stirring blades (15), and the return pipe (11) is provided with return valve (19).

4. The pharmaceutical intermediate transfer tank of claim 1, wherein, Also include handle (16), the top end of cover plate (3) is provided with handle (16).

5. A medical intermediate bulk container as defined in claim 1, wherein, Also include adjustable feet (17), the bottom plate (4) bottom end four corners are respectively provided with a group of adjustable feet (17).

6. A medical intermediate bulk container as defined in claim 1, wherein, Also include observation window (18), the jar (2) is provided with observation window (18).

Images